13/15 For context: GAD affects ~10% of US adults annually. Current treatments often provide inadequate relief, with ~50% experiencing poor response to first-line therapies.
No new GAD medications have been approved since 2007 - highlighting urgent need.
#GADEpidemiology #UnmetNeed
1
0
1
0